PK and PD Study of Oral F/TAF for HIV Prevention

NCT02904369 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Emtricitabine
DRUG: Tenofovir alafenamide
DRUG: Tenofovir disoproxil

Sponsor

CONRAD

Collaborators

[object Object]
[object Object]